Zhuhai Trinomab Pharmaceutical Co., Ltd. (SHA:688806)
China flag China · Delayed Price · Currency is CNY
22.90
-1.16 (-4.82%)
At close: Nov 6, 2026

SHA:688806 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
175.3751.2215.06-4.34
Revenue Growth
1064.77%240.23%---
Gross Profit
121.8222.29-0.23-1.56
Operating Income
-437.69-595.22-517.82-467.79-367.54
Net Income
-450.41-601.32-514.77-446.46-428.67
Earnings Per Share
-1.12-1.56-1.42-1.42-2.68
EPS Growth
-----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
1,329515.37559.41625.53758.35
Total Debt
874.91695.91402.27203.64119.5
Net Cash (Debt)
454.27-180.53157.14421.9638.86
Net Cash Growth
189.08%--62.75%-33.96%-
Net Cash Per Share
1.12-0.470.431.343.99

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-409.45-580.01-369.29-309.09-302.49
Capital Expenditures
-125.56-22.35-16.26-20.86-60.35
Free Cash Flow
-535.01-602.36-385.55-329.96-362.84
Free Cash Flow Growth
-----

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
69.47%43.51%-1.50%-35.95%
Operating Margin
-249.58%-1161.98%-3439.31%--8469.02%
Pretax Margin
-258.91%-1174.00%-3419.05%--9877.68%
Profit Margin
-256.84%-1173.88%-3419.05%--9877.67%
FCF Margin
-305.08%-1175.92%-2560.78%--8360.75%